EVFM (Evofem Biosciences) Inventories, Raw Materials & Components: $0.17 Mil (As of Mar. 2026)


What is Evofem Biosciences Inventories, Raw Materials & Components?

Evofem Biosciences EVFM -6.07% Inventories, Raw Materials & Components is $0.17 Mil as of Mar. 2026. The stock has 5 warning signs investors should review.

Evofem Biosciences's inventories, raw materials & components for the quarter that ended in Mar. 2026 was $0.17 Mil.

Evofem Biosciences's quarterly raw materials increased from Sep. 2025 ($0.13 Mil) to Dec. 2025 ($0.21 Mil) but then declined from Dec. 2025 ($0.21 Mil) to Mar. 2026 ($0.17 Mil).

Evofem Biosciences's annual raw materials declined from Dec. 2023 ($0.52 Mil) to Dec. 2024 ($0.35 Mil) and declined from Dec. 2024 ($0.35 Mil) to Dec. 2025 ($0.21 Mil).

Evofem Biosciences Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Evofem Biosciences's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evofem Biosciences Inventories, Raw Materials & Components Chart

Evofem Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.52 0.35 0.21

Evofem Biosciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.37 0.11 0.13 0.21 0.17

Evofem Biosciences Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of $0.17 Mil mean?
Evofem Biosciences (EVFM) has a Inventories, Raw Materials & Components of $0.17 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on Evofem Biosciences and its competitors.
Is Evofem Biosciences' Inventories, Raw Materials & Components too high?
Evofem Biosciences' current Inventories, Raw Materials & Components is $0.17 Mil.
How does Evofem Biosciences' Inventories, Raw Materials & Components compare to PTIX and ATXI?
Evofem Biosciences' Inventories, Raw Materials & Components of $0.17 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Biotechnology company?
A good Inventories, Raw Materials & Components depends on the Biotechnology industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Evofem Biosciences and its competitors. Evofem Biosciences's current Inventories, Raw Materials & Components is $0.17 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evofem Biosciences stock overvalued right now?
Based on GuruFocus' analysis, Evofem Biosciences (EVFM) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.01, compared to a current price of $0.01 — trading 18% below its estimated fair value. The current Inventories, Raw Materials & Components is $0.17 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Evofem Biosciences (EVFM), the current Inventories, Raw Materials & Components is $0.17 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Evofem Biosciences Business Description

Address 7770 Regents Road, Suite 113-618, San Diego, CA, USA, 92122
Evofem Biosciences Inc is a commercial-stage biopharmaceutical company committed to developing and commercializing products to address unmet needs in women's sexual and reproductive health. The company's product, Phexxi (lactic acid, citric acid, and potassium bitartrate), is a hormone-free, prescription vaginal gel approved in the United States for the prevention of pregnancy.